Editas Medicine, Inc.
Editas Medicine, Inc. (EDIT) is a publicly traded company in the Unknown sector. Across all available filings, 36 corporate insiders have executed 372 transactions totaling $71.9M, demonstrating a bearish sentiment with -$62.5M in net insider flow. The most recent transaction on Dec 3, 2025 involved a sale of 461 shares valued at $991.
EDIT Insider Activity Summary
Who Is Buying EDIT Stock?
No significant insider buying has been recorded for EDIT in the recent period.
Who Is Selling EDIT Stock?
No significant insider selling has been recorded for EDIT in the recent period.
Is Editas Medicine, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EDIT is bearish with an Insider Alignment Score of 7/100 and a net flow of -$62.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
EDIT Frequently Asked Questions
Understanding EDIT Insider Activity
Insider trading at Editas Medicine, Inc. (EDIT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 36 insiders are actively trading EDIT stock, having executed 372 transactions in the past 90 days. The most active insider is Kevin Bitterman (Executive), who has made 14 transactions totaling $31.2M.
Related Tools
Track Editas Medicine, Inc. Insider Activity
Get notified when executives and directors at EDIT file new Form 4 transactions